SoliPharma is a specialty pharmaceutical company
Bring Challenging Molecules to the Global Markets faster and better through providing comprehensive solutions in the global pharmaceutical marketplace.
SoliPharma’s mission is to bring challenging molecules to global markets faster and better through SoliTech® Solutions. We focus on providing comprehensive solutions to our clients worldwide from early API development (solid form screening/crystallization process), to drug product development (formulation/analytical chemistry), until obtaining the final approval of market authorization (FDA GMP/regulatory affair).
Since the inception of SoliPharma, SoliPharma has experienced an exponential growth both in the type of services provided, as well as the breadth and depth of the product portfolio we own. Based on already demonstrated business model, SoliPharma strives to be a technology-driven and market-driven company, and will keep forging ahead on our path to success.
With our track record in product innovation and business relationship, SoliPharma strives for delivering both innovative products (505(b)2 with modified release/new combinations) and difficult generic products (NTI, highly variable, IP hurdles etc). We are devoted to bringing medical products faster to meet patients’ urgent and unmet medical needs.
SoliPharma team believe in core value of Never Compromise Integrity. We aim to the mission of Bring Challenging Molecules to Global Markets and envision ourselves to be the Leader of Specialty Pharmaceutical Products. Empowered by SoliTech® technology, we dedicate to deliver high quality drug faster to the patients to address their unmet medical needs.
Our mission is to Bring Challenging Molecules to the Global Markets faster and better through providing comprehensive solutions in the global pharmaceutical marketplace.
HOTLINE ( +86 571 ) 8649 9471
Bring Challenging Molecules to Global Markets!